Pharmaceutical Commerce

JULY 3, 2024

The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product.

Gene Therapy 52

Gene Therapy Gene Branding Manufacturing 52

Pharmaceutical Technology

JUNE 29, 2022

The next wave of medicine is well on course to be cell and gene-based. In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

STAT News

JANUARY 11, 2023

The company expects its Covid-19 antiviral pill to be launched in the Chinese market on Friday, but noted that Sinopharm is the only legally authorized distributor there of molnupiravir, which is sold under the brand name Lagevrio and was developed by Merck and Ridgeback Biotherapeutics.

Gene Therapy 98

Gene Therapy Licensing Licensing Gene 98

The Pharma Data

MAY 26, 2023

With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Clinical Supply 52

Clinical Supply Gene Therapy Gene Development 52

Pharma Marketing Network

FEBRUARY 27, 2025

Introduction In todays digital-first world, content marketing campaigns are no longer optional for pharmaceutical brands. Imagine content marketing as the heartbeat of a pharma brands digital presence. Instead of traditional promotional tactics, pharma brands can use educational content to build credibility.

Branding 52

Branding Marketing Compliance Pharma Companies 52

Pharmaceutical Technology

JULY 28, 2022

Avastin, which is currently used as an off-label therapy for wAMD, is also of interest as Outlook Therapeutics is working on developing a branded version for this indication. A one-time treatment option would represent a significant shift in the treatment burden for wAMD.

Marketing 130

Marketing Gene Therapy FDA Approval Development 130

pharmaphorum

MARCH 31, 2021

Novartis has been steadily building itself into a radio-oncology powerhouse in the last few years, seeing the category as one of four pillars of its cancer business, along with cell and gene therapy, targeted drugs and immunotherapeutics. In 2018 it paid $2.1

Licensing 98

Licensing Licensing Gene Therapy Sales 98

Pharma Marketing Network

DECEMBER 21, 2020

those that modify the expression of an individual’s genes or repair abnormal genes) has entered clinical practice, including 11 RNA therapeutics, 2 in vivo gene therapies, and 2 gene-modified cell therapies. greater safety, transient and reversible effect on gene expression).

Genetics 52

Genetics Medicine Gene Therapy Marketing 52

pharmaphorum

AUGUST 19, 2020

Our community of supply chain experts are looking forward to connecting with you in the digital world, including: Christopher Baldwin , Supply Chain Director, Cell & Gene Therapy¸ GSK. Get your copy of the brand-new agenda for the full list of speakers and sessions. Kawa Chiu , VP CMC Supply Chain, Lyell Immunopharma.

Gene Therapy 52

Gene Therapy Packaging Packaging Branding 52

Pharmaceutical Technology

MAY 23, 2023

In April, the pilot-level Nordic Pharmaceutical Forum (NPF) initiative, representing Finland, Iceland, Norway, Sweden, and Denmark, released an updated strategy document outlining the region’s plans to establish a joint procurement mechanism for medicines, with a declared focus on advanced therapy medicinal products (ATMPs) such as gene therapies.

Medicine 130

Medicine Gene Therapy Marketing Gene 130

pharmaphorum

SEPTEMBER 17, 2021

Havas Life Medicom, ARK and Pharmadoctor top the agency charts AstraZeneca, klarify and Novartis Gene Therapies top the pharma leader board. Among pharma companies and healthcare organisations, the top three companies, taking two Golds each, were AstraZeneca, klarify and Novartis Gene Therapies. Brand promotion.

Gene Therapy 52

Gene Therapy Gene Allergies Life Science 52

pharmaphorum

MARCH 21, 2022

Eli Lilly is investing $700M into genetic medicine, announcing plans to establish a Boston research center, and with the acquisition of Prevail Therapeutics in late 2020, Lilly secured access to two gene therapies that had already advanced into human testing — with one targeting Parkinson’s disease and the other, dementia.

Genetics 52

Genetics Development Drugs Gene Therapy 52

Drug Channels

JUNE 5, 2023

View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.

Pharmacy 74

Pharmacy Gene Therapy Manufacturing Compliance 74

pharmaphorum

MAY 10, 2022

For me, on top of the patient focus, it’s about creating connectivity — bringing your science, data, brand, company at the right moment in the right channel with the right insights to your audience,” Mark Mulder states. That’s a brand-new channel that wasn’t there 10 years ago.

Marketing 98

Marketing Gene Therapy Sales Branding 98

pharmaphorum

FEBRUARY 23, 2021

Mandatory RWE was set out for Novartis’ gene therapy for spinal muscular atrophy (SMA) zolgensma (onasemnogene abeparvovec) in February 2021. Leela worked as an advisor to the Department of Health and Social Care on the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (VPAS).

Marketing 90

Marketing Medicine Gene Therapy Drugs 90

The Pharma Data

JUNE 7, 2023

Since its launch, we have been able to demonstrate how beneficial the OneBio integrated biologics development solution can be to sponsors, saving them time on managing multiple partners, and handoffs between companies,” said Karen Flynn, Catalent’s Interim President, Division Head for BioModalities (Cell, Gene and Protein Therapies). “By

Manufacturing 40

Manufacturing Development Protein Gene Therapy 40

pharmaphorum

JANUARY 4, 2022

Spinraza – which is also an antisense drug originated by Ionis – had the SMA market to itself for a couple of years after its launch in the US in 2017, growing quickly to reach more than $2 billion in 2019 before Novartis’ one-shot gene therapy Zolgensma (onasemnogene abeparvovec) reached the market.

Sales 52

Sales Gene Therapy Marketing Drugs 52

Pharma Marketing Network

FEBRUARY 23, 2023

Donna is an expert in brand building and commercialization. She runs Janssen’s Retina Gene initiatives. AI can help us create a market analog as we go into rare space in gene therapy for the first time.” One biotech company uses AI to find new therapies in old clinical trial data. AI could help patients.

Branding 52

Branding Gene Gene Therapy Marketing 52

XTalks

NOVEMBER 1, 2024

It is a biologic drug available exclusively as a brand-name medication, with no generic or biosimilar forms available. Botox is one of the most prescribed branded treatments for chronic migraine prevention, offering rapid relief with just four treatments per year. Price of Zolgensma: Zolgensma has a price of $2.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

The Pharma Data

MARCH 31, 2022

A significant part of these investments will be made for enhanced capacities in biotechnology, further strengthening the company’s cell and gene therapy production as well as in the expansion of its manufacturing site in Berkeley, USA. The Bayer brand stands for trust, reliability and quality throughout the world.

Production 52

Production Manufacturing Hormones Gene Therapy 52

pharmaphorum

JUNE 16, 2022

NHS England (NHSE) recognises this, pointing to an agreement with Orchard Therapeutics for Libmeldy (atidarsagene autotemcel), a gene therapy for metachromatic leukodystrophy (MLD) as well as spinal muscular atrophy (SMA) therapy, Zolgensma (onasemnogene abeparvovec).

Medicine 52

Medicine Branding Sales Gene Therapy 52

pharmaphorum

APRIL 28, 2022

But the company was inspired to re-brand its rare disease business unit as a response to internal ramp-ups that have occurred over the last few years, Helfgott said. Plus, many of these small players are very good at research, not necessarily at developing or commercialising their brands,” he said.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

The Pharma Data

FEBRUARY 22, 2021

This is particularly true in the case of cell and gene therapies, which could play a major part in improving future health care for our population.”. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. About Bayer. billion euros.

Production 40

Production Vaccination Vaccine Gene Therapy 40

XTalks

AUGUST 30, 2022

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Nusinersen: A Landmark Therapy. Viral Vectors for Gene Delivery to the CNS. Next Steps for Targeted CNS Delivery.

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

DECEMBER 17, 2020

Prior to SpringWorks, Smith was the executive vice president of Gene Therapy at Bamboo Therapeutics. Prior to VMS BioMarketing, Smiley spent 18 years at Eli Lilly and Company in various positions of increasing responsibility in finance, business development, corporate affairs, brand management and business unit leadership roles.

Development 52

Development Gene Therapy Engineer Life Science 52

pharmaphorum

FEBRUARY 1, 2021

In a nod to issues related to some of the recent breakthroughs in cell and gene therapies – which are hard to manufacture – the agency is also hoping to hear more from companies to reassure them about production and supply too. More has emerged on the new guidelines following the consultation.

Marketing 52

Marketing Medicine Pharmacy Gene Therapy 52

The Pharma Data

FEBRUARY 21, 2022

Bayer’s research and development pipeline continues to grow as the company is building on its existing competencies, such as the expertise around small molecules, while expanding into new modalities, including cell and gene therapies. The Bayer brand stands for trust, reliability and quality throughout the world. billion euros.

Radiology 52

Radiology Cardiology Development Production 52

The Pharma Data

MAY 15, 2023

Through our innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drug delivery, we strive to design the right therapies for the right patients.

Antibody 40

Antibody In-Vitro Clinical Development Medicine 40

Pharmaceutical Technology

FEBRUARY 10, 2023

On November 22, 2022, the FDA approved CSL Behring’s Hemgenix (etranacogene dezaparvovec), the first gene therapy treatment for hemophilia B, with a staggering manufacturer price of $3.5 million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Gene Therapy 263

Gene Therapy Marketing Gene Drugs 263

The Pharma Data

APRIL 12, 2023

Through our innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drug delivery, we strive to design the right therapies for the right patients.

Antibody 40

Antibody In-Vitro Development Trials 40

XTalks

SEPTEMBER 12, 2023

By fostering a sense of community, addressing pain points and sharing impactful stories, podcasts can strengthen ties with an audience, drive brand loyalty and help life science organizations position themselves for long-term success in an increasingly competitive landscape. Have questions?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

World of DTC Marketing

JANUARY 31, 2021

So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). Ex vivo (where cells are genetically modified outside the body) cell and gene therapies have generated considerable excitement on their potential to cure previously incurable diseases.

In-Vivo 187

In-Vivo Generic Drugs Drugs Gene Therapy 187

pharmaphorum

SEPTEMBER 21, 2021

Fortunately, we are now experiencing significant progress in gene therapy and other platform approaches targeting rare diseases, with a number of them focused on devastating CNS conditions. This is and should be a priority for our health system. We need to work together to solve it. About the author.

Gene Therapy 90

Gene Therapy Gene Clinical Trials Clinical Trials 90

pharmaphorum

FEBRUARY 16, 2022

Novartis’ gene therapy Zolgensma (onasemnogene abeparvovec-xioi) for SMA. More deals have followed including for non-small cell lung cancer treatment Tecentriq (atezolizumab) and for the most expensive treatment in the world, gene therapy Libmeldy (atidarsagene autotemcel), to treat metachromatic leukodystrophy (MLD).

Marketing 52

Marketing Life Science Medicine Gene Therapy 52

The Pharma Data

MARCH 11, 2021

Second, the biorevolution is driving innovation in all of Bayer’s divisions – with major progress in cell biology, gene editing and data science. One example is the acquisition of Asklepios BioPharmaceutical (AskBio), a leading company in the field of gene therapy. The divisions show attractive mid-term earnings perspectives.

Sales 52

Sales Gene Therapy Marketing Gene 52

The Pharma Data

OCTOBER 15, 2020

Immuno-oncology and CAR T cells energized the field of regenerative medicine, but for cell and gene to deliver on their promises, new, disruptive technologies and new modes of operation are needed. No one know why the retinal cells die off, so we manufacture brand new retinal cells (OpRegen) and implant them,” Culley said.

Manufacturing 52

Manufacturing Gene Therapy Gene Gene Expression 52

pharmaphorum

NOVEMBER 16, 2021

If we want to know how well England is doing on uptake and assess the performance of a deal that covers all branded medicines, more medicines should be looked at. Many NICE approved medicines will also have the potential to bring substantial health gain (think gene therapies as just one example). appeared first on.

Medicine 96

Medicine Branding Gene Therapy Life Science 96